Have $1,000? This Is the Best Coronavirus Stock to Buy Now
Massive growth from COVID testing is hiding an excellent business.
Fulgent Genetics, Inc.(FLGT)
Nasdaq Global Market
FLGT
$104.50
-$6.88
-6.2%
Price as of March 2, 2021, 8:29 p.m. EST
View Interactive FLGT Charts
Fulgent Genetics is a technology company that provides comprehensive diagnostic genetic testing using its proprietary platform, which integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools, and integrated laboratory processes.
Interactive Chart
News & Analysis: Fulgent Genetics, Inc.
1 Green Flag for Fulgent Genetics
Here's why Fulgent stock is running so high.
Is Fulgent Genetics Still a Good Stock to Buy?
It's a volatile stock right now. But the future for genomic testing looks bright.
Is a Short-Squeeze Driving Fulgent Genetics Higher?
The genetic testing services specialist has been on a tear.
Here's 1 Short-Squeeze Stock That's Actually a Smart Pick to Buy and Hold
The long-term prospects for this high-flying stock appear to be very good.
What's Causing the Huge Run-up for Fulgent Genetics Stock?
After a stellar 2020, the genetic testing specialist is starting off this year with a bang.
Why Is Fulgent Genetics Stock So Volatile?
There are two simple reasons.
2 Stocks That Could Double Your Money in 2021
Both of these businesses prospered even during a volatile year -- and the coming months could be even more impressive.
These Were the 5 Best Diagnostics Stocks of 2020
These winners are positioned for gains even after COVID.
Why Fulgent Genetics Stock Is Dropping Today
A Wall Street analyst downgraded the genetics testing provider.
